Corvus Pharmaceuticals (CRVS) Restructuring Costs (2024 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Restructuring Costs of $1.9 million for Q1 2026, up 103.38% year-over-year from $946000.0 in Q1 2025, and up 211.83% quarter-over-quarter from $617000.0 in Q3 2025.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Restructuring Costs (2024 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.9 million for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.34 Bn | 1.13 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.15 Mn |
| Mar 31, 2026 | 1.92 Mn |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 949,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 551,000.00 |
| Mar 31, 2024 | 994,000.00 |